← All trials

NCT06220344

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 2, 2022
Primary completion
Mar 3, 2023
Completion date
Mar 3, 2023
First posted
Jan 23, 2024
Last posted
Jan 25, 2024
Enrollment
80
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.